Full Fed. Circ. Won't Revisit Save Of Illumina DNA Patents

Law360 (August 3, 2020, 7:53 PM EDT) -- The full Federal Circuit on Monday refused to review a decision reviving two Illumina DNA test patents that a lower court had invalidated for claiming only a natural phenomenon, although the original panel revised its opinion to more fully explain its reasoning.

The appeals court denied a petition for en banc rehearing filed by accused infringers Ariosa and Roche, which had argued that the March panel decision was wrong because the patents are "indistinguishable" from others that have been found patent ineligible.

The full court did not disclose how it voted but said it made its decision after the three-judge panel...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!